DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Tech
Published
09 Aug 25
Updated
08 Sep 26
Views
82
Not Invested
Evolv Technologies HoldingsEVLV
EVLV logo
Fair Value
US$8
Share price08 Sep
US$4.9538.1% undervalued intrinsic discount
Loading
1Y-43.49%
7D-1.00%

AI Security Screening Will Face Overwhelming Regulatory And Pricing Headwinds

AN
AnalystLowTarget
AnalystLowTarget

Analyst Low Target compiles bearish analysts opinions to create narratives which represent one standard deviation below the consensus price target, using forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
09 Aug 25
Updated
08 Sep 26
Views
82
Not Invested
Fair ValueUS$8
Share priceUS$4.95
38.1% undervalued intrinsic discount
Narrative
Updates6

Last Update 08 Sep 26

Fair value Decreased 20%

EVLV: 2026 Manufacturing Ramp And New Contracts Will Drive Upside

Analysts have trimmed their fair value estimate for Evolv Technologies Holdings from $10.00 to $8.00. This aligns it with a new $8.00 price target that reflects updated assumptions for revenue growth, profit margins and future P/E expectations following recent research coverage.

What's in the News for Evolv Technologies Holdings

  • Evolv Technologies Holdings renewed and expanded its multi-year hardware and software subscription agreement with the Houston Texans, upgrading the stadium's Evolv Express fleet to Gen2 hardware and deploying the Evolv eXpedite bag screening solution. Source, company client announcement.
  • The renewal with the Houston Texans also extends Evolv’s marketing partnership, with the company designated as the “Official Fan Screening Partner of the Houston Texans,” one of more than 50 similar designations with sports teams and venues in North America. Source, company client announcement.
  • Evolv Technologies Holdings raised its earnings guidance for the year ending December 31, 2026, and now expects total revenue between US$180 million and US$185 million, compared with prior guidance of US$175 million to US$180 million. Source, corporate guidance update.
  • Evolv Express has been selected as the security partner for Northwestern University’s new Ryan Field, under a multi-year agreement that designates Evolv as the university’s “Official Fan Screening Provider” and adds another higher education and stadium deployment to its customer roster. Source, company client announcement.
  • The Evolv eXpedite AI-powered bag screening solution received SAFETY Act Designation from the U.S. Department of Homeland Security. This designation recognizes both eXpedite and Evolv Express as Qualified Anti-Terrorism Technologies and supports wider use across schools, sports venues, hospitals and other public spaces. Source, product-related announcement.

Valuation Changes for Evolv Technologies Holdings

  • Fair Value reduced from $10.00 to $8.00, which is a cut of 20% in the updated model.
  • Discount Rate moved slightly higher from 8.89% to 8.94%, reflecting a modestly higher required return assumption.
  • Revenue Growth raised from 14.93% to 21.04%, indicating a higher $ revenue growth profile in the latest assumptions.
  • Net Profit Margin adjusted down from 7.36% to 6.71%, pointing to slightly lower expected profitability for Evolv Technologies Holdings.
  • Future P/E reduced from 148.58x to 102.38x, implying a lower valuation multiple applied to expected earnings.
Read more
1 viewusers have viewed this narrative update

Key Takeaways

  • Growing regulatory and privacy concerns, alongside commoditization and global competition, threaten Evolv's market adoption and pricing power.
  • Reliance on a narrow product suite and ongoing operating losses risk shareholder dilution and declining recurring revenue visibility due to evolving buyer preferences.
  • Strong demand drivers, subscription-based growth, ongoing innovation, leadership improvements, and expanding partnerships position the company for sustained top-line and margin growth.

Catalysts

About Evolv Technologies Holdings
    Provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Growing public scrutiny over AI-driven surveillance and security, along with the risk of increasingly stringent data privacy regulations like GDPR and CCPA, may sharply hinder adoption of Evolv's solutions in key global markets, leading to slower than projected revenue growth.
  • The rapid commoditization and globalization of security screening technologies could intensify price competition, eroding Evolv's premium pricing and compressing gross and net margins over time as average selling prices fall.
  • A narrow product suite focused on AI-based weapons detection leaves Evolv vulnerable to technological disruption or being outpaced by larger incumbents and new entrants launching integrated or more advanced multi-system security platforms, threatening long-term revenue sustainability and recurring revenue growth.
  • Continued high operating losses, coupled with an ongoing need for significant capital expenditures (as guided between $20 million and $25 million annually) to fund hardware deployment and back-office improvements, increase the likelihood of future shareholder dilution or leveraged balance sheet, suppressing earnings per share.
  • Accelerating shifts in buyer preferences toward more unified, end-to-end security ecosystems may marginalize Evolv's standalone solutions, driving lower contract win rates and declining future bookings, thus weakening the expansion of recurring revenue and contracted forward visibility.
Evolv Technologies Holdings Earnings and Revenue Growth

Evolv Technologies Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • This narrative explores a more pessimistic perspective on Evolv Technologies Holdings compared to the consensus, based on a Fair Value that aligns with the bearish cohort of analysts.
  • The bearish analysts are assuming Evolv Technologies Holdings's revenue will grow by 21.0% annually over the next 3 years.
  • The bearish analysts are not forecasting that Evolv Technologies Holdings will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Evolv Technologies Holdings's profit margin will increase from -3.0% to the average US Electronic industry of 6.7% in 3 years.
  • If Evolv Technologies Holdings's profit margin were to converge on the industry average, you could expect earnings to reach $20.4 million (and earnings per share of $0.1) by about September 2029, up from -$5.2 million today.
  • In order for the above numbers to justify the price target of the more bearish analyst cohort, the company would need to trade at a PE ratio of 102.5x on those 2029 earnings, up from -175.9x today. This future PE is greater than the current PE for the US Electronic industry at 29.8x.
  • The bearish analysts expect the number of shares outstanding to grow by 3.73% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.94%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The company highlighted strong secular demand drivers such as heightened security concerns, the continued prevalence of gun violence, and new state laws mandating automated weapons detection in hospitals, all of which are likely to sustain or increase demand for Evolv's solutions, potentially boosting long-term revenues and supporting future cash flow growth.
  • Evolv's business model is increasingly driven by a subscription and recurring revenue base, as evidenced by an annual recurring revenue of $106 million and retention rates above 90 percent for both units and revenue, which enhances visibility and stability for future revenue streams and could result in improved margin stability.
  • Positive early adoption of its new product, Evolv eXpedite, alongside an active Certified Pre-Owned program, demonstrates ongoing innovation and ability to address both new and price-sensitive market segments, providing potential for expanding total addressable market and supporting long-term topline growth.
  • The company has successfully resolved significant regulatory and accounting challenges, instituted new leadership with track records in scaling technology businesses, and enacted operational improvements resulting in reduced expenses and first-time positive adjusted EBITDA, which could improve future net margins and enhance investor confidence.
  • Expanding partnerships and deployments in diverse verticals, including sports venues, education, and health care, coupled with legislative trends such as new security mandates, may lead to further multi-year contract wins and compounding revenue growth as industry-wide adoption of AI-enabled, frictionless security accelerates.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bearish price target for Evolv Technologies Holdings is $8.0, which represents up to two standard deviations below the consensus price target of $9.85. This valuation is based on what can be assumed as the expectations of Evolv Technologies Holdings's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $11.25, and the most bearish reporting a price target of just $8.0.
  • In order for you to agree with the more bearish analyst cohort, you'd need to believe that by 2029, revenues will be $304.0 million, earnings will come to $20.4 million, and it would be trading on a PE ratio of 102.5x, assuming you use a discount rate of 8.9%.
  • Given the current share price of $5.07, the analyst price target of $8.0 is 36.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Evolv Technologies Holdings?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystLowTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystLowTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystLowTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

EVLV logo
Evolv Technologies Holdings
52.9% undervalued intrinsic discount

Urbanization And AI Will Revolutionize Touchless Screening

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 16 Jun
Read Narrative
EVLV logo
Evolv Technologies Holdings
50.5% undervalued intrinsic discount

Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 2 May
Read Narrative

Fair Value vs Share Price

US$8
vs US$4.9538.1% undervalued intrinsic discount
PastFuture-120m304m2019202120232025202620272029Revenue US$304.0mEarnings US$20.4m
21%
Revenue growth
6.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Evolv Technologies Holdings

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and slightly overvalued.

Market capUS$895.7m
PB7.5x
Estimated Growth17.4%
Dividend YieldN/A
Full analysis

CEO & management

John Kedzierski
CEO
2.2yrs
CEO Tenure

Develops, manufactures, markets, and sells security screening products and specific services in the United States and internationally.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide